PHC Announces Exclusive Distribution of MaxCyte® ExPERT™ Platform in Japan
TOKYO, July 1 (Bernama-BUSINESS WIRE) — The Biomedical Division of PHC Corporation (Headquarters: Chiyoda-ku, Tokyo; President: Nobuaki Nakamura; hereafter referred to as “PHCbi”), a subsidiary of PHC Holdings Corporation (Headquarters: Chiyoda-ku, Tokyo, hereafter referred to as “PHCHD”) announces it has signed an exclusive agreement with MaxCyte, Inc. to distribute the MaxCyte…

